WCN26-4862 CHANGES IN TOTAL KIDNEY VOLUME IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC DISEASE USING DAPAGLIFLOZIN

Read full text Summarise with VIRAT
Authors: Magdy Mohamed Elsharkawy, Tamer Elsaid, Shaimaa Zaki Abdelmegied, Nourhan Hossam Eldin, Mahmoud Rabie, Mostafa Abdelnasier Abdelgawad
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

One of the mechanisms of action of SGLT2i is increasing ketones such as β-hydroxybutyrate. The renal cyst cells in autosomal dominant polycystic kidney disease (ADPKD) seem to be metabolically inflexible. This study assessed the effect of oral dapagliflozin on the progression of total kidney volume and chronic kidney disease (CKD) in patients with ADPKD.

Fields of Study & Subjects

Genetic and Kidney Cyst Diseases Chronic Kidney Disease and Diabetes Tuberous Sclerosis Complex Research

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104343–104343
Publication date
25 March 2026
Language
EN